TAMPA, Fla.– H. Lee Moffitt Cancer Center & Research Institute’s Dr. James J. Mulé, Associate Center Director and the Michael McGillicuddy Endowed Chair for Melanoma Research and Treatment has been appointed to the Florida Technology, Research and Scholarship Board. His appointment will last four years.
Florida House Speaker Allan Bense appointed Mulé to the prestigious board. Members are representatives from business, industry, academia, science and leaders in the emerging and advanced technology sector.
“I am absolutely delighted and honored by an important opportunity to serve the state of Florida and the public through this highly visionary and innovative initiative to further advance high-powered science and technology to the benefit of our great state’s citizens and its economy,” says Mulé.
The board was created in January to guide the establishment of Centers of Excellence and the attraction of world-class scholars. The board is charged with recommending criteria to the Board of Governors for the 21st Century World Class Scholars Program and with providing guidance to the Board of Governors and administration of the Centers of Excellence.
In 2001, H. Lee Moffitt Cancer Center & Research Institute earned NCI Comprehensive Cancer Center status in recognition of its excellence in research and contributions to
clinical trials, prevention and cancer control. Additionally, Moffitt is a member of the
National Comprehensive Cancer Network, a prestigious alliance of the country's leading cancer centers, and is listed in the U.S. News & World Report as one of the top cancer hospitals in America. Moffitt’s sole mission is to contribute to the prevention and cure of cancer.